8-K
filed June 16, 2023, 7:59 PM ET
ticker TXG
CIK 0001770787
other
confidence high
sentiment neutral
materiality 0.10
Stockholders approve director elections, auditor, and say-on-pay at 2023 annual meeting
10x Genomics, Inc.
- Three Class I directors elected: Hindson, Saxonov, Stuelpnagel, each with >88% votes for.
- Ratification of Ernst & Young as independent auditor for FY2023 approved (99.9% votes for).
- Non-binding advisory vote on executive compensation passed with ~82% support (188M for, 39M against).
- Quorum achieved with 85.5% of eligible votes represented (238.3M of 278.8M votes).
- All proposals passed; no broker non-votes on auditor ratification.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
10x Genomics, Inc. shareholders approved Election of three Class I directors at the 2023-06-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The Company’s stockholders approved the election of three Class I directors, each to hold office for a three-year term expiring at the Company’s 2026 annual meeting of stockholders or until his respective successor has been duly elected and qualified or until his or her earlier resignation or removal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
10x Genomics, Inc. shareholders approved Non-binding, Advisory Vote to Approve Executive Compensation of Named Executive Officers at the 2023-06-14 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as described in more detail in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 28, 2023.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
10x Genomics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2023-06-14 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.